DSCSA Digital Enablement Solutions
Aeologic delivers DSCSA Digital Enablement Solutions that help pharmaceutical manufacturers, distributors, and exporters achieve serialization, end-to-end traceability, and audit-ready compliance for the US pharmaceutical supply chain.
Enable US Market Access with DSCSA-Ready Digital Systems
The Drug Supply Chain Security Act (DSCSA) is a federal law governing pharmaceutical distribution in the United States.
DSCSA compliance is mandatory:
- Non-compliance blocks US market access
- Trading partners demand electronic interoperability
- Paper records and manual evidence are rejected
Aeologic helps pharma organizations implement DSCSA-compliant digital traceability systems that meet FDA expectations and trading partner requirements.
Why Pharma Companies Struggle With DSCSA Compliance
Most DSCSA failures are system failures, not intent failures:
- Serialization data fragmented across systems
- Gaps in aggregation between unit, case, and pallet levels
- Poor EPCIS interoperability with trading partners
- Manual, high-risk audit preparation
Aeologic addresses these challenges by building integrated, interoperable, and inspection-ready compliance ecosystems.
Our DSCSA Digital Enablement Services
Serialization & Aggregation
Unit, case, and pallet-level serialization with secure serial number management and parent-child aggregation logic.
EPCIS & Trading Partner Interoperability
EPCIS-based data exchange, transaction verification, and exception workflows aligned with FDA expectations.
Secure Digital Audit Trails
Electronic records aligned with 21 CFR Part 11, time-stamped events, and instant inspection readiness.
Cold Chain & Asset Visibility (Optional)
Temperature monitoring, shipment condition proof, and risk mitigation for sensitive pharma products.
Why Choose Aeologic for DSCSA Enablement
- Deep pharmaceutical and compliance domain expertise
- Proven serialization and EPCIS implementations
- Regulation-driven, audit-first system design
- End-to-end delivery from readiness assessment to deployment
- Built for FDA inspections, partner scrutiny, and scale
Pharma Ecosystem Segments We Support
-
Manufacturers –
Serialization, commissioning, aggregation, and EPCIS compliance. -
Distributors & Wholesalers –
Transaction verification, exception handling, and audit-ready traceability. -
Export-Focused Pharma Companies –
FDA inspection readiness, partner onboarding, and zero-tolerance compliance.
Technologies We Use
Serialization & Aggregation Platforms
EPCIS Integration Frameworks
Secure Cloud & Compliance Middleware
Audit & Compliance Dashboards
All solutions are secure, interoperable, scalable, and FDA-aligned.
Key Benefits of Aeologic DSCSA Enablement
-
Uninterrupted US Market Access –
Avoid distribution blocks and penalties -
End-to-End Traceability –
Unit-to-pallet visibility across the supply chain -
Trading Partner Interoperability –
Seamless EPCIS data exchange -
Audit Readiness –
Always-prepared FDA inspection evidence -
Reduced Compliance Risk –
Automated verification and exception handling -
Scalability –
Future-ready systems aligned with evolving DSCSA mandates
Start With a DSCSA Digital Readiness Assessment
Aeologic offers a no-obligation DSCSA Digital Readiness Review, covering:
- Serialization and aggregation gaps
- EPCIS interoperability readiness
- FDA inspection risk areas
- Practical digital roadmap for continuous DSCSA compliance
Latest Insights
Stay updated with our thoughts on technology, industry trends, and innovation.
Blog
How Enterprises Scale AI from Pilot to Production
March 24, 2026
Artificial intelligence has moved beyond experimentation and is now a core driver of enterprise innovation, efficiency,...
Read More
Blog
The Role of IoT Solutions in Agriculture Industry in India
March 23, 2026
The agricultural sector in India is undergoing a significant transformation driven by digital technologies, data intelli...
Read More
Blog
AI Staff Augmentation for Enterprise AI Projects
March 20, 2026
In today’s rapidly evolving digital landscape, enterprises are racing to adopt artificial intelligence to gain a competi...
Read More
Blog
How to Automate Manual Business Processes Using AI
March 20, 2026
In today’s competitive business landscape, manual processes are one of the biggest barriers to growth, efficiency, and s...
Read MoreFrequently Asked Questions (FAQs)
It is the implementation of digital serialization, traceability, and interoperability systems required to comply with DSCSA regulations.
No. Aeologic builds the digital systems required to pass FDA inspections and trading partner audits.
Yes. EPCIS is the standard for interoperable transaction data exchange between trading partners.
Yes. Our solutions support electronic records and audit trails aligned with 21 CFR Part 11 requirements.
Absolutely. Our platforms are designed to adapt to future DSCSA updates and partner requirements.
Get In Touch
Let's discuss how we can help you achieve your goals. We're here to listen.
Send Us a Message
Direct Assistance & Quick Info
Contact Directly
support@aeologic.com +91-120-3200058 +91-120-3200059 +1 917-382-5712 (USA)Mon - Fri, 9:00 AM - 6:00 PM (IST)
Looking for Quick Answers?
Our Office
Plot no. C-28 & 29, C Block, Phase 2, Industrial Area,
Sector 62, Noida, Uttar Pradesh-201309
Sales Offices
United States
Jacksonville
3897 Eunice Road, Jacksonville, Florida 32250
United Kingdom
London
37 Millharbour, South Quay, London E14 9HB
South Africa
Parktown North
Johannesburg 2193
